Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:CELG
Tag: NASDAQ:CELG
CELGENE CORPORATION (NASDAQ:CELG) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
June 14, 2017
0
Celgene Corporation (NASDAQ:CELG) MS Drug Was Successful In Second Late-Stage Study
-
May 23, 2017
0
CELGENE CORPORATION (NASDAQ:CELG) Files An 8-K Other Events
ME Staff 8-k
-
May 22, 2017
0
CELGENE CORPORATION (NASDAQ:CELG) Files An 8-K Results of Operations and Financial...
ME Staff 8-k
-
April 27, 2017
0
Celgene Corporation (NASDAQ:CELG) Cambridge Expansion Drive Gathers Momentum
-
April 24, 2017
0
CELGENE CORPORATION (NASDAQ:CELG) Files An 8-K Other Events
ME Staff 8-k
-
April 4, 2017
0
CELGENE CORPORATION (NASDAQ:CELG) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
February 23, 2017
0
CELGENE CORPORATION (NASDAQ:CELG) Files An 8-K Other Events
ME Staff 8-k
-
February 20, 2017
0
Pharmaceutical Executives From Merck & Co., Inc. (NYSE:MRK), Johnson & Johnson...
Andy Parker
-
February 1, 2017
0
Celgene Corporation (NASDAQ:CELG) To Acquire Autoimmune Firm Delinia for $775 Million
-
January 27, 2017
0
1
...
9
10
11
12
Page 10 of 12
